TITLE

Review: Proton-pump inhibitor therapy reduces symptoms in nonulcer dyspepsia better than placebo

PUB. DATE
May 2005
SOURCE
ACP Journal Club;May/Jun2005, Vol. 142 Issue 3, p74
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article presents a study, which reports that proton-pump inhibitor (PPI) therapy reduces symptoms in nonulcer dyspepsia (NUD) better than placebo. The study method consisted of randomized controlled trials that compared PPI therapy with placebo, receptor antagonists, prokinetic therapy, antacids, or mucosal protection agents and assessed symptoms of dyspepsia as an outcome in patients who had negative findings endoscopy. The main result showed that more patients who received PPI therapy had relief of dyspepsia than did those who received placebo.
ACCESSION #
17116542

 

Related Articles

  • Lansoprazole ineffective for functional dyspepsia. Mounsey, Anne L. // Journal of Family Practice;Dec2002, Vol. 51 Issue 12, p1015 

    The article discusses research being done on the efficacy of different doses of lansoprazole, a proton pump inhibitor, on the treatment of functional dyspepsia. It references a study by W. M. Wong, B. C. Wong, W. K. Hung et al published in the 2002 issue of "Gut." The study found that...

  • Study supports NICE on dyspepsia. Baines, Emma // GP: General Practitioner;5/24/2004, p19 

    Treatment with a proton pump inhibitor (PPI) followed by test-and-treat for Helicobacter pylori is the best strategy for managing patients with dyspepsia, according to Dutch research. The findings support recommendations made by NICE in its draft guidance on the management of chronic dyspepsia,...

  • Review: Proton-pump inhibitor therapy reduces symptoms in nonulcer dyspepsia better than placebo: COMMENTARY. Veldhuyzen Van Zanten, Sander J. // ACP Journal Club;May/Jun2005, Vol. 142 Issue 3, p74 

    This article reports that the diagnosis of nonulcer dyspepsia (NUD) requires a normal endoscopy result, but this is poorly handled in a study, which reported that proton-pump inhibitor therapy reduces symptoms in nonulcer dyspepsia better than placebo. Before having endoscopy, many patients take...

  • Picking a PPI: It comes down to cost. Wigle, Patricia R.; Hein, Brad; Ellis, Robert; Austin, Orson; Kiesler, Joseph; Gait, Kimberly A. // Journal of Family Practice;Apr2008, Vol. 57 Issue 4, p231 

    The article offers tips in choosing the right proton pump inhibitor (PPI) for patients with heartburn in the U.S. A 33-year-old man complained about the occurrence of heartburns after he attempted to lose weight and try to exercise to manage his hypertension. To address the problem, it is...

  • Acid suppression and paediatric asthma. Birring, S. // Thorax;Nov2005, Vol. 60 Issue 11, p973 

    The article focuses on acid suppression and paediactric asthma. Gastro-oesophageal reflux is common in children with asthma but its relevance is unclear. The effects of proton pump inhibitors on asthma control in children are not known. Thirty six children aged 7-16 years with mild to moderate...

  • Rabeprazole: A Viewpoint by Noriaki Takeguchi. Takeguchi, N. // Drugs;Feb1998, Vol. 55 Issue 2, p268 

    Presents a viewpoint on the efficacy of rabeprazole against acid-related disorders. Mechanism of action of the medication; Characteristics as a proton pump inhibitor.

  • Rabeprazole: A Viewpoint by Simmy Bank. Bank, S. // Drugs;Feb1998, Vol. 55 Issue 2, p268 

    Presents a viewpoint on the efficacy of rabeprazole against acid-related disorders. Mechanism of action; Characteristics as a proton pump inhibitor; Results of clinical trials on the medication.

  • Clinical Pharmacology of Proton Pump Inhibitors: What the Practising Physician Needs to Know. Robinson, Malcolm; Horn, John // Drugs;2003, Vol. 63 Issue 24, p2739 

    Proton pump inhibitors (PPIs) [omeprazole, lansoprazole, pantoprazole, rabeprazole and esomeprazole] are widely utilised for the treatment of gastro-oesophageal reflux disease, as well as other acid-related disorders. All PPIs suppress gastric acid secretion by blocking the gastric acid pump,...

  • Pilot Study of On-Demand Therapy with Pantoprazole 20mg for Long-Term Treatment in Patients with Mild Gastro-Oesophageal Reflux Disease. Scholten, Theo; Pustlauk, Uwe; Sander, Peter; Bohuschke, Martina; Gatz, Gudrun // Clinical Drug Investigation;2005, Vol. 25 Issue 10, p633 

    Background: Few clinical studies have demonstrated the efficacy of proton pump inhibitors (PPIs) as on-demand therapy for the long-term management of patients with mild gastro-oesophageal reflux disease (GORD). On-demand therapy with pantoprazole 20mg may offer an effective strategy for the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics